Search Results

CG Oncology Reports Bladder Cancer Treatment: Phase 3 trial shows 75% remission rate.

• Authors : BRENNAN, PETER J.

Subjects: *CLINICAL trials; *BLADDER cancer; *CANCER treatment

• Source: Orange County Business Journal. 5/13/2024, Vol. 47 Issue 20, p1-4. 2p.

Record details

Advancements in Bladder Cancer Treatment Are Providing Hope.

• Authors : Cukier, Abigail (AUTHOR)

Subjects: BLADDER cancer; CANCER treatment; HOPE

• Source: Maclean's. Oct2022, Vol. 135 Issue 9, p(Sp)4-(Sp)4. 1p. 1 Color Photograph.

Record details

Emerging Treatments in Bladder Cancer.

• Authors : Filon, Mikolaj¹; Schmidt, Bogdana¹

Subjects: *CANCER treatment; *BLADDER cancer; *BCG immunotherapy

• Source: AUANews. Jul2024, Vol. 29 Issue 7, p4-6. 3p.

Record details

Intravesical instillation-based mTOR-STAT3 dual targeting for bladder cancer treatment.

• Authors : Lee, Dae Hoon; Yoo, Jung Ki; Um, Ki Hwan

Subjects: BLADDER cancer; NON-muscle invasive bladder cancer; CANCER treatment

• Source: Journal of Experimental & Clinical Cancer Research (17569966); 6/18/2024, Vol. 43 Issue 1, p1-22, 22p

Record details

Mathematical model of MMC chemotherapy for non-invasive bladder cancer treatment.

• Authors : Yosef, Marom; Bunimovich-Mendrazitsky, Svetlana

Subjects: BLADDER cancer; NON-muscle invasive bladder cancer; CANCER treatment

• Source: Frontiers in Oncology; 2024, p1-17, 17p

Record details

EARLY CLINICAL EXPERIENCE WITH SEQUENTIAL INTRAVESICAL GEMCITABINE-DOCETAXEL FOR TREATMENT-NAIVE HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER.

• Authors : Refugia, Justin Manuel¹ (AUTHOR); Roebuck, Emily¹ (AUTHOR); Thakker, Parth U.¹ (AUTHOR)

Subjects: *BLADDER cancer; *NON-muscle invasive bladder cancer; *CANCER treatment

• Source: Urologic Oncology. Mar2024:Supplement, Vol. 42, pS49-S50. 2p.

Record details

Spatial relationship of tertiary lymphoid structures and tumor‐associated neutrophils in bladder cancer and prognostic potential for anti‐PD‐L1 immunotherapy

• Authors : Wang, Xuechun; Juncker‐Jensen, Anna; Huang, Gang

• Source: Cancer Communications. April, 2024, Vol. 44 Issue 4, p499, 5 p.

Record details

Prediction of immunotherapy response of bladder cancer with a pyroptosis-related signature indicating tumor immune microenvironment.

• Authors : Zihan Xu; Yujie Zhao; Yong Zhang

Subjects: TREATMENT effectiveness; TUMOR microenvironment; BLADDER cancer

• Source: Frontiers in Pharmacology; 2024, p01-18, 18p

Record details

Gut microbiota Parabacteroides distasonis enchances the efficacy of immunotherapy for bladder cancer by activating anti-tumor immune responses.

• Authors : Wang, Benlin; Qiu, Yifeng; Xie, Ming

Subjects: GUT microbiome; BLADDER cancer; ENTEROTYPES

• Source: BMC Microbiology; 7/3/2024, Vol. 24 Issue 1, p1-15, 15p

Record details

Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en‐bloc transurethral resection.

• Authors : Yanagisawa, Takafumi; Sato, Shun; Hayashida, Yasushi

Subjects: PROGNOSIS; BLADDER cancer; PROGRESSION-free survival

• Source: Histopathology; Jul2024, Vol. 85 Issue 1, p92-103, 12p

Record details